Comparison Avalo Therapeutics (AVTX) with Competitors
Avalo Therapeutics (AVTX) industry is Biotechnology.
Operating Margin
AVTX-33461.00%
Industry-2055.25%
Upside-31405.75%
Free Cash Flow Yield
AVTX-12.74%
Industry-1.75%
Upside-11.00%
P/E
AVTX-3.90
Industry-20.52
Upside+1661.53%
P/S
AVTX9875.25
Industry10.01
Upside+98519.02%
P/B
AVTX3.78
Industry5.15
Upside-26.54%